KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for Resmed (RMD) over the last 7 years, with Q4 2025 value amounting to $12.4 million.

  • Resmed's Amortizatization of Intangibles rose 3151.22% to $12.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $41.3 million, marking a year-over-year increase of 153.12%. This contributed to the annual value of $37.3 million for FY2025, which is 508.66% down from last year.
  • According to the latest figures from Q4 2025, Resmed's Amortizatization of Intangibles is $12.4 million, which was up 3151.22% from $10.0 million recorded in Q3 2025.
  • Resmed's Amortizatization of Intangibles' 5-year high stood at $12.4 million during Q4 2025, with a 5-year trough of $7.6 million in Q2 2022.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $8.7 million (2021), whereas its average is $9.1 million.
  • In the last 5 years, Resmed's Amortizatization of Intangibles surged by 3241.64% in 2024 and then plummeted by 2626.25% in 2025.
  • Over the past 5 years, Resmed's Amortizatization of Intangibles (Quarter) stood at $8.8 million in 2021, then dropped by 11.85% to $7.8 million in 2022, then rose by 10.47% to $8.6 million in 2023, then rose by 10.21% to $9.5 million in 2024, then skyrocketed by 31.51% to $12.4 million in 2025.
  • Its last three reported values are $12.4 million in Q4 2025, $10.0 million for Q3 2025, and $10.7 million during Q2 2025.